Startup & VC Daily Briefing · 23 Jun 2026 · 5 min

Baseten's $1.5B, Sarvam, Meta-CRED & Europe's Fintech Drop

AI inference infrastructure attracts billion-dollar bets as Baseten closes a $1.5B Series F and Upscale AI hits a $2B valuation — capital is moving down the stack fast. Today's briefing also covers Sarvam AI's India LLM raise, Meta's reported $4B CRED play, and a sharp 31% decline in European fintech funding.

Startup & VC Daily Briefing
Now Playing
Baseten's $1.5B, Sarvam, Meta-CRED & Europe's Fintech Drop

Audio is available on Spreaker — see link below.

What's covered

Inference Becomes Venture Battleground

Baseten just raised one point five billion dollars for AI inference infrastructure, and that number tells you more about where the AI economy is heading than almost any model release this year. Inference isn't the glamorous part of the AI stack.

Listen now →

Upscale AI and Networking Arms Race

Baseten isn't alone. Upscale AI hit a two billion dollar valuation on a one hundred ninety million dollar raise for AI cluster networking, backed by Nvidia and Salesforce Ventures.

Listen now →

Nearfield and Geopolitical Semiconductor Capital

The geopolitical layer of this story runs through a Dutch semiconductor tooling company called Nearfield, which raised five hundred twenty-seven point six million dollars with backing from Temasek, QIA, and M&G. That combination of sovereign wealth funds entering what was previously a pure-venture category is a signal worth tracking.

Listen now →

Sarvam AI and India's LLM Threshold

India's Sarvam AI raised two hundred thirty-four million dollars at a one point five billion dollar valuation, led by HCLTech, to build Indian-language models and enterprise infrastructure. That's the largest India deal in the past week, and it marks something worth noting.

Listen now →

Meta's CRED Play and European Fintech Decline

Meta is reportedly in early talks to invest four billion dollars in the Indian premium fintech CRED. The context matters here.

Listen now →

Biotech Precision and Fomo's Crypto Wedge

Two smaller raises round out the picture. French biotech Bionyra raised one hundred sixty-five million in a Series A on the back of a specific mechanism thesis in inflammatory disease, not a broad platform claim.

Listen now →

Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.

More episodes

From Startup & VC Daily Briefing